1. Home
  2. ARLO vs CAPR Comparison

ARLO vs CAPR Comparison

Compare ARLO & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$12.67

Market Cap

1.4B

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$25.29

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARLO
CAPR
Founded
2018
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
ARLO
CAPR
Price
$12.67
$25.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$24.00
$44.63
AVG Volume (30 Days)
1.2M
805.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
145.16
N/A
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$9.29
N/A
Revenue Next Year
$8.82
$3.31
P/E Ratio
$94.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.05
$4.30
52 Week High
$19.94
$40.37

Technical Indicators

Market Signals
Indicator
ARLO
CAPR
Relative Strength Index (RSI) 41.57 32.86
Support Level $11.94 $21.56
Resistance Level $14.35 $25.70
Average True Range (ATR) 0.49 1.16
MACD -0.04 -0.26
Stochastic Oscillator 24.43 8.94

Price Performance

Historical Comparison
ARLO
CAPR

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: